Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 11, 2010HaematologicaOpen Access

Different response to salvage chemotherapy but similar post-transplant outcomes in patients with relapsed and refractory Hodgkin's lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

NPNoemí PuigInstituto de Investigación Biomédica de SalamancaMPMelania PintiliePrincess Margaret Cancer CentreTSTara SeshadriEuropean Society for Blood and Marrow Transplantation

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Puig et al. (2010) studied this question.

synapsesocial.com/papers/6a225641e15916edff82a971https://doi.org/10.3324/haematol.2009.019943
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease before intensive therapy and autologous bone marrow transplantation.1995 · 92 citations
  2. 2Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure.1992 · 377 citations
  3. 3Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.1997 · 182 citations
  4. 4Long‐term follow‐up in patients treated with Mini‐BEAM as salvage therapy for relapsed or refractory Hodgkin's disease2001 · 91 citations
  5. 5Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy‐proven primary refractory Hodgkin's disease2004 · 169 citations